Besarwani, K., & Gupta, R
Amylin: pharmacology, physiology, and clinical potential
Public and private payers are gradually recognizing obesity as a chronic disease, improving affordability for eligible patients and encouraging physicians to prescribe GLP-1 therapies
For patients and adults using GLP-1 medications Download the free GLP-1 Muscle-Preserving Weight-Loss Checklist This patient-friendly guide includes: What to monitor beyond body weight Practical resistance-training and nutrition guidance Strength and function self-checks Hydration and appetite considerations Warning signs to discuss with a clinician A printable monthly tracking page For clinicians Download the GLP-1 Muscle-Preserving Weight-Loss Clinician Companion The clinician companion includes: Baseline risk-screening prompts Strength and function assessment options Protein and kidney-disease considerations Resistance-training counseling Follow-up and referral considerations Documentation language Body-composition and sarcopenia terminology guardrails Claims that should not be overstated These resources are designed to support a more complete weight-loss conversation: not merely how much weight was lost, but whether strength, function, nutrition, and physical resilience were preserved
Motta, M
It is often included in aesthetic and wellness treatments but should always be administered under the supervision of a qualified healthcare professional for safety and effectiveness
